These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
60 related items for PubMed ID: 1772578
1. Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. Volpi R, Scaglioni A, Marcato A, Caffarra P, Rossi G, Caffarri G, Delsignore R, Chiodera P, Coiro V. J Neural Transm Park Dis Dement Sect; 1991; 3(4):259-64. PubMed ID: 1772578 [Abstract] [Full Text] [Related]
2. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men. Coiro V, Capretti L, Bianconi L, Castelli A, Cerri L, Roberti G, Marcato A, Volpi R, Chiodera P. Horm Metab Res; 1991 Dec; 23(12):600-4. PubMed ID: 1663914 [Abstract] [Full Text] [Related]
3. Different control mechanisms of growth hormone (GH) secretion between gamma-amino- and gamma-hydroxy-butyric acid: neuroendocrine evidence in Parkinson's disease. Volpi R, Chiodera P, Caffarra P, Scaglioni A, Saccani A, Coiro V. Psychoneuroendocrinology; 1997 Oct; 22(7):531-8. PubMed ID: 9373886 [Abstract] [Full Text] [Related]
19. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C. Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061 [Abstract] [Full Text] [Related]
20. Different control of GH secretion by gamma-amino- and gamma-hydroxy-butyric acid in 4-year abstinent alcoholics. Vescovi PP, Coiro V. Drug Alcohol Depend; 2001 Feb 01; 61(3):217-21. PubMed ID: 11164685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]